196-210 of 894
Modern Approaches to Long-Term Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerModern Approaches to Long-Term Metastatic Breast Cancer Care
Charles Turck, PharmD, BCPS, BCCCP
Adam Brufsky, MD, PhD
The Metabolic Roots of Early-Onset Colorectal Cancer
Project Oncology®The Metabolic Roots of Early-Onset Colorectal Cancer
Exercise in CRC Survivors: A Closer Look at Biomarker Effects
Project Oncology®Exercise in CRC Survivors: A Closer Look at Biomarker Effects
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Project Oncology®AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
How COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
Clinician's RoundtableHow COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
Redefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy
Deep Breaths: Updates from CHESTRedefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy
Gerard A. Silvestri MD, MS
Mariam Alexander, MD, PhD
Jessica S. Donington, MD, MSCR
- advertisement
Clinical Updates in Non-Small Cell Lung Cancer: From Surveillance to Treatment
Deep Breaths: Updates from CHESTClinical Updates in Non-Small Cell Lung Cancer: From Surveillance to Treatment
Gerard A. Silvestri MD, MS
Adam H. Fox, MD, MSc
Anurag Singh, MD, PhD
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Alexandria May, PharmD, BCPS
Nicholas Whipple, MD, MPH
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Project Oncology®Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Pavani Chalasani, MD, MPH
Timothy Yap, MBBS, PhD, FRCP
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Project Oncology®From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Seth Wander, MD, PhD
Tracking Tumor Resistance in Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerTracking Tumor Resistance in Metastatic Breast Cancer Care
Ryan Quigley
Megan Kruse, MD
Optimizing Monitoring after Ide-cel in RRMM: What the Evidence Shows
AudioAbstractsOptimizing Monitoring after Ide-cel in RRMM: What the Evidence Shows
Marlene Mimi Maeusli, PhD.
- advertisement
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Project Oncology®Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Ryan Quigley
Kathrin M. Bernt, MD
Rushabh Mehta, BS
Fatemeh Alikarami
Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Project Oncology®Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Alexandria May, PharmD, BCPS
Daniel Landi, MD
Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Project Oncology®Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Casey Cosgrove, MD
